The North American Neuroendocrine Tumor Society (NANETS) is dedicated to educating medical professionals on the diagnosis and treatment of NET disease and supporting research and innovation in the field.

NET disease educational programming is designed exclusively for medical professionals, by leading medical professionals in the field. All members of NANETS benefit from the on-going sharing of medical knowledge and experience and the constant exchange of the very latest information in NET disease diagnosis, treatment and supportive care.

NANETS is a 501(C)3 non-profit medical society that hosts regional NET education conferences and an annual symposium that features sessions on the latest NET disease diagnosis, treatment and management presented by well-known leaders and experts in the field. The annual symposium is also an opportunity to recognize outstanding work being done in NET research through the call for abstracts. Abstracts are compiled in a yearly publication and serve as a comprehensive guide to the latest in NET research.

Each year, NANETS provides research grants to young investigators doing preeminent NET research. Grants available through NANETS were established to both support new research initiatives and welcome young and eager scientific minds to the NET community. Currently, NANETS has four grants available: the Basic/Translational Science Investigator (BTSI), the NANETS Clinical Investigator Scholarship (NCIS), the NANETS Theranostics Investigator Grant (NTIG), and the NANETS Young Investigator (YI) Award. These annual grants support innovative research initiatives and encourage young researchers and scientific clinicians to become NET specialists.

NANETS also seeks to standardize treatment and management of NET disease through the development of consensus guidelines. These guidelines serve as important educational material for medical professionals working with NET patients and provide an overview of treatment. They are quick, accessible references for practicing physicians.